After graduating from medical school in 2009 from the Aga Khan University in Karachi, Pakistan, Dr. Haider Warraich joined the internal medicine residency program at the Beth Israel Deaconess Medical Center, affiliated with Harvard Medical School. After three years of training and a year practicing hospital medicine there, Dr. Warraich moved to join Duke University Medical Center in Durham, North Carolina, where he completed training in cardiology and advanced heart failure and transplantation over 4 years.

In 2019, after completing his training, Dr. Warraich returned to Boston to join the VA Boston Healthcare System, where he would become Director of the Heart Failure Program. He also began working as a faculty member practicing at Brigham and Women’s Hospital, and an assistant professor at Harvard Medical School. In 2023, he joined the US Food and Drug Administration (FDA) as a Senior Clinical Advisor for Chronic Disease to the FDA Commissioner Dr. Robert Califf. In this role, Dr. Warraich worked closely with FDA leadership, its Centers, other federal agencies and various stakeholders to shape policy across drugs, devices, nutrition, tobacco and AI as it pertains to chronic disease.

After the conclusion of his FDA term, he joined ARPA-H, a new federal research agency designed to make transformative investments in health. ARPA-H is modeled after DARPA, the legendary defense research agency responsible for inventions such as the internet, GPS, stealth technology, and driverless cars.